// App-Quantinova.ai

1409 : Prophylaxis of Invasive Pulmonary Aspergillosis with Nebulized Lipid Complex Amphotericin B Is Feasible, Well Tolerated and Safe in Children with Acute Leukemia. Results of a Phase II Open Trial

Researchers

Presenter

  • Maria Trabazo

Principal Investigators

  • Albert Catala

  • Ruben Berrueco

  • Joan Vinent

  • Maria Luisa Martin-Saenz

  • Cristina Llanos

  • Gabriela Corbalan

  • Anna Ruiz

  • Maria Poveda

  • Mireia Camos

  • Montserrat Torrebadell

  • Teresa Toll

  • Anna Alonso

  • Montserrat Mesegue

Medical Centers

  • Hematology Laboratory, Hospital Sant Joan de Deu, University of Barcelona, Esplugues de Llobregat (Barcelona), Spain

  • Hematology Laboratory, Hospital Sant Joan de Deu, University of Barcelona, Esplugues de Llobregat (Barcelona), Spain

  • Hematology Laboratory, Hospital Sant Joan de Deu, University of Barcelona, Esplugues de Llobregat (Barcelona), Spain

  • Hematology Laboratory, Hospital Sant Joan de Deu, University of Barcelona, Esplugues de Llobregat (Barcelona), Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Acute Leukemia

  • Neutropenia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • amphotericin b cholesteryl sulfate complex Intravenous

  • Fluconazole

  • Vincristine

  • azoles

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved